Summary The effect of sodium butyrate on mouse and human melanoma cell lines was evaluated. Sodium butyrate (0.1-2mM) is shown to reduce the clonogenic potential of several melanoma cell lines. The antiproliferative effect of sodium butyrate is accompanied by a marked increase in the activity of the plasmamembrane bound enzyme y-glutamyl transpeptidase. Sodium butyrate treated cells acquire a well developed rough endoplasmic reticulum and accumulate fat droplets. The development of the endoplasmic reticulum is associated with a marked increase in the activity of the enzyme marker NADPH cytochrome c reductase. It is suggested that the phenotypic alterations induced by sodium butyrate may serve as markers for the action of this agent on melanoma cells and other tumours.Butyric acid, a natural four carbon fatty acid, is known as an inducer of differentiation in Friend erythroleukaemic cells (Leder & Leder, 1975;Reeves & Cserjesi, 1979). In vivo application of sodium butyrate to a child with acute myelogenous leukaemia resulted in a partial remission (Novogrodsky et al., 1983).Butyric acid (or its sodium salt) also induce phenotypic alterations in a variety of solid tumour cell lines such as Hela cells (Fishman et al., 1974;Gosh & Cox, 1976), neuroblastoma (Prasad, 1979;Rama & Prasad, 1984), breast cancer cells (Abe & Kufe, 1984;Stevens et al., 1984, colorectal carcinoma (Dexter et al., 1981;Kim et al., 1980; Hertz & Halwer, 1982) and retinoblastoma (Kyritsis et al., 1984). The anti-tumour effects of sodium butyrate that include growth inhibition and decrease in tumorigenicity (for review see Prasad, 1980; Wright, 1973;Leavitt et al., 1978;Reese et al., 1985; Nordenberg et al., 1986a, b) are accompanied by changes in enzyme activities (Simmons et al., 1975;Prasad, 1980;Dexter et al., 1981;Prager & Kanar, 1984), receptor content (Fishman & Atikkan, 1979;Jahangeer et al., 1982) and histone structure (Sealy & Chulkley, 1978;Rubenstein et al., 1979).We have recently shown that sodium butyrate markedly inhibits B 16 mouse melanoma cell growth and alters the morphologic appearance of these cells. Growth inhibition was accompanied by a marked inhibition of tyrosinase activity (Nordenberg et al., 1986a).In the present study we further evaluate the effects of sodium butyrate on mouse melanoma cells and expand our studies to human malignant melanoma cells. Sodium butyrate is shown to inhibit clonogenicity of the different melanoma cells in soft agar. This anti-proliferative effect of sodium butyrate is associated with a marked increase in the activities of the plasma membrane bound enzyme y-glutamyl transpeptidase and NADPH cytochrome c reductase, a marker of the well developed endoplasmic reticulum.These phenotypic alterations may serve as markers for butyrate activity on melanoma cells in basic and clinical studies.